TRP_1170x120_12-19-19

National Council for Prescription Drug Programs

NACDS: Progress made on Medicare Part D changes

NACDS: Progress made on Medicare Part D changes

ARLINGTON, Va. – The National Association of Chain Drug Stores has analyzed the Centers for Medicare & Medicaid Services’ (CMS) proposed Medicare Part D changes, and found progress on topics related to advancing e-prescribing and medication therapy management (MTM); further addressing opioid issues in a pro-patient and pro-pharmacy manner; and fostering pharmacy access. CMS’ approaches

NCPDP’s Stember named among ‘Most Powerful Women in Healthcare IT’

NCPDP’s Stember named among ‘Most Powerful Women in Healthcare IT’

SCOTTSDALE, Ariz. — Lee Ann Stember, president of the National Council for Prescription Drug Programs (NCPDP), has been named as one of the “Most Powerful Women in Healthcare IT” by health care journal Health Data Management. “This is a tremendous honor,” Stember said in a statement. “Just last week we held NCPDP’s 40th Anniversary Conference

McNeil Consumer Healthcare becomes NCPDP Elite Partner

McNeil Consumer Healthcare becomes NCPDP Elite Partner

SCOTTSDALE, Ariz. — McNeil Consumer Healthcare has joined the National Council for Prescription Drug Programs (NCPDP) Elite Partner Program. NCPDP said Wednesday that the Elite Partner Program establishes the highest level of sustained support for the council’s efforts to advance patient safety and interoperability. Elite Partners make a three-year commitment. The program provides critical support

AmerisourceBergen becomes NCPDP Elite Partner

AmerisourceBergen becomes NCPDP Elite Partner

SCOTTSDALE, Ariz. — AmerisourceBergen Corp. has joined the National Council for Prescription Drug Programs’ Elite Partner Program. NCPDP said Tuesday that as an Elite Partner, AmerisourceBergen will provide critical support of the valuable standards development and other work of NCPDP, including its continuing evolution as a forum for health care business, patient safety issues, education, new product development and the

NCPDP advises on biosimilars

NCPDP advises on biosimilars

The National Council for Prescription Drug Programs took part in the meeting that may result in the rollout of the nation’s first biosimilar medication. John Klimek, senior vice president for standards and industry information technology at NCPDP, addressed the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) and Oncologic Drugs Advisory Committee (ODAC)